Home › Macular Degeneration › Florida › St. Petersburg

Macular Degeneration clinical trials in St. Petersburg, FL

4 studies for Macular Degeneration are looking for participants at sites in and around St. Petersburg (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

RecruitingPhase 2/3

Retina Vitreous Associates of Florida (Site 049), St. Petersburg

Ages 50 and older · All sexes · Updated Oct 2, 2026 · NCT07440225

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

RecruitingPhase 2/3

Retina Vitreous Associates of Florida, St. Petersburg

Ages 60 and older · All sexes · Updated Sep 30, 2026 · NCT06635148

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

RecruitingPhase 3

Retina Vitreous Associates of Florida Saint Petersburg, St. Petersburg
Eye Associates of Pinellas, Pinellas Park · 5 mi away

Ages 50 to 85 · All sexes · Updated Sep 18, 2026 · NCT06541704

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

RecruitingPhase 3

Retina Vitreous Associates of Florida, St. Petersburg

Ages 50 and older · All sexes · Updated Apr 16, 2026 · NCT07064759

About Macular Degeneration

Macular degeneration, or age-related macular degeneration (AMD), causes vision loss in older adults. Learn about the types and what can help.

More about Macular Degeneration on MedlinePlus

Macular Degeneration trials in other cities

Other studies in St. Petersburg

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.